Log In
BCIQ
Print this Print this
 

AN2718

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionBoron-containing small molecule that inhibits leucyl-tRNA synthetase (LARS; LeuRS)
Molecular Target Leucyl-tRNA synthetase (LARS) (LeuRS)
Mechanism of ActionLeucyl-tRNA synthetase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationFungal infection
Indication DetailsTreat fungal infection of the skin and nails
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$5,200.0M

$5,200.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/24/2016

$5,200.0M

$5,200.0M

0

Get a free BioCentury trial today